Anti-Drug Antibodies Detected in the Presence of Adequate Infliximab Drug Levels In IBD Patients in Clinical Remission have Limited Clinical Significance

被引：0
|
作者：
Doherty, J. [1 ]
Varley, R. [1 ]
Healy, M. [2 ]
Dunne, C. [1 ]
Mac Carthy, F. [1 ]
McKiernan, S. [1 ]
Hartery, K. [1 ]
Kevans, D. [1 ]
机构：
[1] St James Hosp, Dept Gastroenterol, Dublin 8, Ireland
[2] St James Hosp, Dept Biochem, Dublin 8, Ireland
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab076.532
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P408
引用
收藏
页码：S415 / S416
页数：3
相关论文
共 50 条
  • [21] Neutralizing anti-drug antibodies in Fabry disease have no obvious clinical impact?
    Lenders, Malte
    Schmitz, Boris
    Brand, Stefan-Martin
    Brand, Eva
    ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
  • [22] Real world use of biologic drug levels and anti-drug antibodies in patients with psoriasis - does therapeutic drug monitoring have a place in routine clinical practice?
    Kearney, Niamh
    McKenna, Kevin
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2022, 33 (03) : 1676 - 1681
  • [23] ANTI INFLIXIMAB ANTIBODIES DETECTED BY A DRUG TOLERANT ASSAY ARE FREQUENT BUT, IN MANY CASES, WITHOUT RELEVANT CLINICAL SIGNIFICANCE
    Martinez-Feito, A.
    Hernandez-Breijo, B.
    Novella-Navarro, M.
    Navarro-Compan, V.
    Diego, C.
    Monjo, I.
    Nuno, L.
    Villalva, A.
    Peiteado, D.
    Pascual-Salcedo, D.
    Nozal, P.
    Balsa, A.
    Plasencia, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 546 - 546
  • [24] The clinical and immunological significance of low level of infliximab in the absence of anti-infliximab antibodies in patients with IBD
    Ungar, B.
    Anafy, A.
    Yavzori, M.
    Picard, O.
    Fudim, E.
    Kopylov, U.
    Ron, Y.
    Yanai, H.
    Dotan, I.
    Chowers, Y.
    Eliakim, R.
    Ben-Horin, S.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S113 - S113
  • [25] The Clinical and Immunological Significance of Low Level of Infliximab in the Absence of Anti-Infliximab Antibodies in Patients With IBD
    Ungar, Bella
    Anafy, Adi
    Kopylov, Uri
    Ron, Yulia
    Yanai, Henit
    Dotan, Iris
    Chowers, Yehuda
    Eliakim, Abraham R.
    Ben-Horin, Shomron
    GASTROENTEROLOGY, 2014, 146 (05) : S245 - S245
  • [26] BARRIERS AGAINST TESTING ANTI-TNF DRUG LEVELS AND ANTI-DRUG ANTIBODIES IN ROUTINE CLINICAL PRACTICE
    Gavan, S. P.
    Daker-White, G.
    Payne, K.
    Barton, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1726 - 1727
  • [27] Anti-tumor necrosis factor drug therapy: The usefulness of monitoring drug levels and anti-drug antibodies in clinical practice
    Garcia Ruiz de Morales, Jose M.
    Pascual-Salcedo, Dora
    Llinares Tello, Francisca
    Valor Mendez, Larissa
    MEDICINA CLINICA, 2016, 147 (09): : 410 - 416
  • [28] Anti-drug antibodies in psoriasis: a critical evaluation of clinical significance and impact on treatment response
    Hsu, Leeyen
    Armstrong, April W.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (10) : 949 - 958
  • [29] Clinical Utility of Measuring Infliximab (IFX) and Adalimumab (ADA) and Anti-drug Antibody Levels Using the LabCorp Assay in Patients With Inflammatory Bowel Disease (IBD)
    Brown, Sara
    Perinbasekar, Rajiv
    Syed, Nauroz
    Lonsako, Shumet
    Cross, Raymond
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S406 - S406
  • [30] THE PRESENCE OF TOTAL ANTI-DRUG ANTIBODIES TO BIOLOGIC DRUGS DOES NOT ADVERSELY AFFECT LONG-TERM OUTCOMES IN CROHN'S DISEASE PATIENTS WITH ADEQUATE DRUGS LEVELS AND ABSENT FREE ANTI-DRUG ANTIBODIES
    Samaan, M. A.
    Unsworth, N.
    Ward, M.
    Warner, B.
    Sanderson, J. D.
    Arkir, Z.
    Irving, P. M.
    GUT, 2016, 65 : A255 - A256
12345